prof. Gwen Sys

Mitochondrial DNA ddPCR as an alternative to Alu-repeats for quantifying metastatic burden in CAM assays

Shari Aerts (UGent) , Hilde De Rooster (UGent) , Gwen Sys (UGent) and Ward De Spiegelaere (UGent)

(2025) European Digital PCR Symposium & Workshop (EUDIP 2025), Abstracts.

The CAM assay as a model to investigate the invasive character of canine sarcomas

Shari Aerts (UGent) , Ellis Clappaert, Hilde De Rooster (UGent) , Gwen Sys (UGent) , Hilde De Cock (UGent) and Ward De Spiegelaere (UGent)

(2025) ANATOMIA HISTOLOGIA EMBRYOLOGIA. In Anatomia, Histologia, Embryologia 54(Supplement 1). p.23-23

Add to list

Miscellaneous
open access

Correction : Kalisvaart et al. Relative wash-in rate in dynamic contrast-enhanced magnetic resonance imaging as a new prognostic biomarker for event-free survival in 82 patients with osteosarcoma : a multicenter study

Gijsbert M. Kalisvaart, Richard E. Evenhuis, Willem Grootjans, Thomas Van Den Berghe (UGent) , Martijn Callens, Judith V. M. G. Bovée, David Creytens (UGent) , Hans Gelderblom, Frank M. Speetjens, Lore Lapeire (UGent) , et al.

(2025) CANCERS. 17(16).

Add to list

Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI : development and external validation of a predictive model

Thomas Van Den Berghe (UGent) , Gijsbert M. Kalisvaart, Willem Grootjans, Maryse Lejoly (UGent) , Wouter Huysse (UGent) , Judith V.M.G. Bovée, David Creytens (UGent) , Hans Gelderblom, Frank M. Speetjens, Lore Lapeire (UGent) , et al.

(2025) Annual Congress ESSR & SIMS Joint Meeting 2025, Abstracts.

Add to list

Monitoring denosumab therapy of giant cell tumours of bone using a radiological-pathological correlation

Thomas Van Den Berghe (UGent) , Maryse Lejoly (UGent) , Wouter Huysse (UGent) , David Creytens (UGent) , Lore Lapeire (UGent) , Gwen Sys (UGent) and Koenraad Verstraete (UGent)

(2025) Annual Congress ESSR & SIMS Joint Meeting 2025, Abstracts.

Add to list

Evaluation of the value of (dynamic) contrast-enhanced MRI for the diagnosis and follow-up of central cartilage tumours

Thomas Van Den Berghe (UGent) , Maryse Lejoly (UGent) , Felix Delbare, Wouter Huysse (UGent) , David Creytens (UGent) , Gwen Sys (UGent) and Koenraad Verstraete (UGent)

(2025) Annual Congress ESSR & SIMS Joint Meeting 2025, Abstracts.

Add to list

Relative wash-in rate on dynamic contrast-enhanced MRI as a new prognostic factor in patients with osteosarcoma after neoadjuvant chemotherapy?

Thomas Van Den Berghe (UGent) , Gijsbert M. Kalisvaart, Richard E. Evenhuis, Willem Grootjans, Judith V.M.G. Bovée, David Creytens (UGent) , Hans Gelderblom, Frank M. Speetjens, Lore Lapeire (UGent) , Gwen Sys (UGent) , et al.

(2025) Annual Congress ESSR & SIMS Joint Meeting 2025, Abstracts.

Add to list

Journal Article
A1
open access

Exact radiological-pathological correlation of chondrosarcomas using a patient-specific 3D mold

Maryse Lejoly (UGent) , Thomas Van Den Berghe (UGent) , David Creytens (UGent) , Wouter Huysse (UGent) , Gwen Sys (UGent) , Renaat Coopman (UGent) and Koenraad Verstraete (UGent)

(2025) SKELETAL RADIOLOGY. 54(10). p.2179-2190

Add to list

Identifying novel treatments for sarcoma through relevant surgical mouse models

Stefanie Gijsels (UGent) , Suzanne Fischer (UGent) , Lotte Legiest, Gabriëlle van Ramshorst (UGent) , Gwen Sys (UGent) and Olivier De Wever (UGent)

(2025) OncoPoint Symposium, 11th, Abstracts.

Add to list

Journal Article
A1
open access

Preserving potential : surgeons as key partners in establishing a living sarcoma biobank for translational research purposes

Stefanie Gijsels (UGent) , Merlijn Vekeman (UGent) , Suzanne Fischer (UGent) , David Creytens (UGent) , Alexander Ackerman, Anaïs Ongenaet, Laurens Boi, Eline Segers, Jens De Temmerman (UGent) , Francesca Casteur, et al.

(2025) SURGICAL ONCOLOGY-OXFORD. 59.

Academic Bibliography

prof. Gwen Sys

Mitochondrial DNA ddPCR as an alternative to Alu-repeats for quantifying metastatic burden in CAM assays

The CAM assay as a model to investigate the invasive character of canine sarcomas

Correction : Kalisvaart et al. Relative wash-in rate in dynamic contrast-enhanced magnetic resonance imaging as a new prognostic biomarker for event-free survival in 82 patients with osteosarcoma : a multicenter study

Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI : development and external validation of a predictive model

Monitoring denosumab therapy of giant cell tumours of bone using a radiological-pathological correlation

Evaluation of the value of (dynamic) contrast-enhanced MRI for the diagnosis and follow-up of central cartilage tumours

Relative wash-in rate on dynamic contrast-enhanced MRI as a new prognostic factor in patients with osteosarcoma after neoadjuvant chemotherapy?

Exact radiological-pathological correlation of chondrosarcomas using a patient-specific 3D mold

Identifying novel treatments for sarcoma through relevant surgical mouse models

Preserving potential : surgeons as key partners in establishing a living sarcoma biobank for translational research purposes

Contents

Support

Contact